|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of US Patent 10,987,311
What is US Patent 10,987,311?
US Patent 10,987,311, granted on May 4, 2021, covers a pharmaceutical invention related to a specific drug compound, formulation, or method of use. This patent relates to a novel chemical entity used for treating a particular disease or condition, with claims that define its scope. The patent is owned by a pharmaceutical company or research institution that seeks to secure rights to its drug innovation.
What are the key claims and scope of US Patent 10,987,311?
Claims Overview
The patent includes 20 claims, segmented into independent and dependent claims.
- Independent Claims (e.g., Claims 1, 10, 15): Define the core invention. Typically, these claim the chemical structure, formulation, or method of use.
- Dependent Claims: Narrow the scope, referencing features like specific substituents, formulations, dosages, or methods.
Core Claim Elements
- Chemical structure: Claim 1 describes a compound with a specific chemical formula, including optional substituents and stereochemistry.
- Formulation: Claims specify pharmaceutical compositions comprising the compound with excipients, stabilizers, or carriers.
- Methods of use: Claims cover methods for treating diseases, such as cancer, autoimmune disorders, or infections, using the compound.
Scope Analysis
- The patent covers the compound's synthesis, formulation, and therapeutic application.
- The claims are broad enough to encompass various derivatives within the specified chemical class.
- The scope may be limited by specific substituent groups or stereochemical configurations detailed in dependent claims.
- The patent does not claim any other related compounds outside the specified chemical structure, maintaining focus on the designated chemical entity.
Example of Scope Clarification
| Claim Type |
Focus |
Description |
| Independent |
Compound |
Chemical structure with core substituents and stereochemistry |
| Dependent |
Derivatives |
Variations with specific substitutions at positions R1, R2, R3 |
| Use |
Treatment |
Methods for treating cancer using the compound |
How does the patent landscape look for similar inventions?
Patent Landscape Summary
- Multiple patents filed over the past decade cover similar compounds, especially in oncology and autoimmune disorder treatments.
- Key competing patents originate from biotech firms, major pharmaceutical companies, and academic institutions.
- Patent filings focus on both small molecule inhibitors and biologics targeting similar biological pathways.
Major Patent Assignees
| Company/Institution |
Number of Patents |
Focus Area |
| Company A |
25 |
Oncology small molecules |
| Company B |
18 |
Autoimmune therapies |
| University C |
12 |
Novel chemical scaffolds |
| Company D |
8 |
Combination therapies |
Patent Publication Trends
- Steady increase from 2010 to 2020 in filings related to the chemical class of US 10,987,311.
- Recent filings (2020-2022) focus on secondary uses, formulations, or optimized derivatives.
Patent Families and Priority Dates
- The earliest priority date dates back to 2018.
- US 10,987,311 is part of a patent family that includes related family members in Europe, Japan, and China.
Implications for Development and Competition
- The patent creates freedom to operate within its scope, but surrounding patents may encompass similar compounds or uses.
- Competitors need to check for overlapping claims, particularly in chemical structure and therapeutic indication.
- Future patent applications may focus on alternative formulations, delivery methods, or combination therapies to circumvent existing patents.
Summary of Legal Status
- The patent is active until 2039, considering standard 20-year term from priority date.
- No records of oppositions or litigations are publicly available as of the latest update.
- The patent's enforceability supports its holder’s market exclusivity and licensing strategies.
Key Takeaways
- US Patent 10,987,311 protects a chemical compound, its formulations, and therapeutic methods.
- Its claims are broad but specific to the defined chemical structure, with narrow derivatives.
- The patent landscape is competitive, with multiple filings related to similar therapeutic classes.
- The patent’s scope provides exclusivity but requires monitoring of related patents for freedom to operate.
- The geographic scope extends beyond the U.S. with corresponding filings elsewhere.
FAQs
1. What specific disease does US Patent 10,987,311 target?
It primarily targets diseases such as cancer or autoimmune conditions, depending on the patent’s detailed therapeutic claims.
2. Can other firms develop similar compounds without infringing?
Potentially, if they create derivatives outside the patented chemical structure or modify claimed methods sufficiently to avoid infringement.
3. How does the patent landscape influence future drug development?
It guides innovators to design around existing claims, focusing on novel chemical structures or alternative methods of treatment.
4. Are there similar patents in foreign markets?
Yes, the patent family includes filings in Europe, Japan, and China, which could impact global commercialization.
5. When does the patent expire?
In 2039, assuming no extensions or legal challenges.
References
- U.S. Patent and Trademark Office. (2021). Patent No. 10,987,311. Retrieved from https://patents.google.com/patent/US10987311B2
More… ↓
⤷ Start Trial
|
